Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3827 Prevalence of Clonal Hematopoiesis (CH) in neuroendocrine tumor (NET) patients prior to Lutetium 177 dotatate therapy (Lu177) and the risk of cytopenia – A prospective study of 37 patients

Introduction: Lu177 has shown efficacy in advanced NET but with significant hematologic toxicity, including therapy-related myeloid neoplasm (t-MN). CH is defined by acquisition of somatic mutations in hematopoietic stem cells with potential for expansion over time.

Conference:

Presenting Author: Sonbol M

Authors: Sonbol M, Kusne Y, Lasho T, Elsabbagh Z, Mangaonkar A,

Keywords: clonal hematopoiesis, neuroendocrine, PRRT, Lu177, t-MN, CHIP,

#3674 COVID-19 in patients with neuroendocrine neoplasms – Two-year results of a worldwide survey (The INTENSIVE study)

Introduction: Preliminary results regarding 85 patients of the INTENSIVE study have been published in 2021.

Conference:

Presenting Author: Gervaso L

Authors: Fazio N, Gervaso L, Halfdanarson T, Sonbol M, Pusceddu S,

Keywords: neuroendocrine, NEN, COVID-19, SARS-CoV-2,

#3336 Management of early-stage lung carcinoid: Analysis of NCDB database

Introduction: There is paucity of data to direct the management of resectable lung carcinoids.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Rakshit S

Authors: Rakshit S, Zhu M, Fuentes H, Leventakos K, Sonbol M,

Keywords: carcinoid, surgery, NCDB, prognosis,

#3254 COVID-19 in patients with neuroendocrine tumors (NETs): The Mayo Clinic experience

Introduction: Coronavirus Disease 2019 (COVID-19) has been associated with increased morbidity and mortality in cancer patients. NETs are rare and there is paucity of data about COVID-19 outcomes.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Rakshit S

Authors: Rakshit S, Lee K, Kendi A, Sonbol M, Starr J,

Keywords: neuroendocrine tumor, covid-19, outcomes, mortality,

#3012 Causes of Death Following Neuroendocrine Tumors Diagnosis: A United States Population-Based Analysis

Introduction: Neuroendocrine tumors (NET) are heterogeneous in terms of prognosis based on location, grade, and stage.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Sonbol M

Authors: Saad A, Halfdanarson T, Starr J, Sonbol M,

Keywords: neuroendocrine tumors, survivorship, non-cancer causes of death,